These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11801671)

  • 1. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice.
    Sing A; Roggenkamp A; Geiger AM; Heesemann J
    J Immunol; 2002 Feb; 168(3):1315-21. PubMed ID: 11801671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model.
    Sing A; Tvardovskaia N; Rost D; Kirschning CJ; Wagner H; Heesemann J
    Int J Med Microbiol; 2003 Nov; 293(5):341-8. PubMed ID: 14695062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence.
    Sing A; Reithmeier-Rost D; Granfors K; Hill J; Roggenkamp A; Heesemann J
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16049-54. PubMed ID: 16239347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yersinia V antigen induces both TLR homo- and heterotolerance in an IL-10-involving manner.
    Reithmeier-Rost D; Bierschenk S; Filippova N; Schröder-Braunstein J; Sing A
    Cell Immunol; 2004; 231(1-2):63-74. PubMed ID: 15919371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression.
    Sing A; Rost D; Tvardovskaia N; Roggenkamp A; Wiedemann A; Kirschning CJ; Aepfelbacher M; Heesemann J
    J Exp Med; 2002 Oct; 196(8):1017-24. PubMed ID: 12391013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial cytokine antagonists encoded by pathogenic yersiniae.
    Beuscher HU; Burdack S; Röllinghoff M
    Behring Inst Mitt; 1997 Feb; (98):240-8. PubMed ID: 9382746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial evasion of host immune defense: Yersinia enterocolitica encodes a suppressor for tumor necrosis factor alpha expression.
    Beuscher HU; Rödel F; Forsberg A; Röllinghoff M
    Infect Immun; 1995 Apr; 63(4):1270-7. PubMed ID: 7890384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype 08 by macrophages.
    Roggenkamp A; Leitritz L; Sing A; Kempf VA; Baus K; Heesemann J
    Med Microbiol Immunol; 1999 Dec; 188(3):151-9. PubMed ID: 10776846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen.
    Roggenkamp A; Geiger AM; Leitritz L; Kessler A; Heesemann J
    Infect Immun; 1997 Feb; 65(2):446-51. PubMed ID: 9009295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis.
    Philipovskiy AV; Cowan C; Wulff-Strobel CR; Burnett SH; Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
    Infect Immun; 2005 Mar; 73(3):1532-42. PubMed ID: 15731051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rLcrV and rYopB from Yersinia pestis on murine peritoneal macrophages in vitro.
    Sharma RK; Sodhi A; Batra HV; Tuteja U
    Immunol Lett; 2004 May; 93(2-3):179-87. PubMed ID: 15158615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yersinia rLcrV and rYopB inhibits the activation of murine peritoneal macrophages in vitro.
    Sodhi A; Sharma RK; Batra HV
    Immunol Lett; 2005 Jul; 99(2):146-52. PubMed ID: 16009264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Yersinia enterocolitica evasion of the host innate immune response by V antigen.
    Sing A; Rost D; Tvardovskaia N; Roggenkamp A; Geiger AM; Kirschning CJ; Wiedemann A; Aepfelbacher M; Heesemann J
    Adv Exp Med Biol; 2003; 529():165-7. PubMed ID: 12756751
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis.
    Pouliot K; Pan N; Wang S; Lu S; Lien E; Goguen JD
    Infect Immun; 2007 Jul; 75(7):3571-80. PubMed ID: 17438030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
    Bohn E; Autenrieth IB
    J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha expression induced by anti-YopB antibodies coincides with protection against Yersinia enterocolitica infection in mice.
    Burdack S; Schmidt A; Knieschies E; Röllinghoff M; Beuscher HU
    Med Microbiol Immunol; 1997 Mar; 185(4):223-9. PubMed ID: 9138294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yersinia enterocolitica promotes robust mucosal inflammatory T-cell immunity in murine neonates.
    Echeverry A; Saijo S; Schesser K; Adkins B
    Infect Immun; 2010 Aug; 78(8):3595-608. PubMed ID: 20515925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.
    Abramov VM; Khlebnikov VS; Vasiliev AM; Kosarev IV; Vasilenko RN; Kulikova NL; Khodyakova AV; Evstigneev VI; Uversky VN; Motin VL; Smirnov GB; Brubaker RR
    J Proteome Res; 2007 Jun; 6(6):2222-31. PubMed ID: 17441749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis.
    Reithmeier-Rost D; Hill J; Elvin SJ; Williamson D; Dittmann S; Schmid A; Wilharm G; Sing A
    Microbes Infect; 2007 Jul; 9(8):997-1002. PubMed ID: 17556003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains.
    Bohn E; Schmitt E; Bielfeldt C; Noll A; Schulte R; Autenrieth IB
    Infect Immun; 1998 May; 66(5):2213-20. PubMed ID: 9573110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.